Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H22 Hepatocellular Carcinoma-Bearing Mice: By Targeting Myeloid-Derived Suppressor Cells

Frontiers in Pharmacology
Yingjie XieChangjun Wang

Abstract

Tumor-induced immunosuppressive microenvironment in which myeloid-derived suppressor cells (MDSCs) plays an important role, remains an obstacle for effective oncotherapy currently. Inducing MDSCs into maturation was confirmed as an effective method to reduce the tumor-bearing host's immunosuppression. Traditional Chinese medicines (TCM) possess characteristics of alleviating immunosuppression of cancer patients and low toxicity. Jianpi Huayu Decoction (JHD) was an experienced formula of TCM for oncotherapy based on TCM theory and clinical practice. We previously observed that JHD attenuated the expression of interleukin-10 (IL-10) and transforming growth factor beta (TGF-β) in tumor. IL-10 and TGF-β were found to be cytokines positively related to immunosuppression induced by MDSCs. Here, our study was designed to further investigate the regulation of JHD on the immune system in the H22 liver-cancer mouse model. Mainly, flow cytometry was used to detect the proportion of immune cells, to analyze the apoptosis, differentiation and reactive oxygen species of MDSCs. We found that JHD significantly reduced the destruction of spleen structure, reduced the proportion of regulatory T cells (Treg) and T helper 17 cells (Th17), and incr...Continue Reading

References

Nov 17, 2007·Cancer Research·Yulia NefedovaDmitry I Gabrilovich
Jul 18, 2015·Orvosi hetilap·Lajos Jakab
Oct 7, 2016·Frontiers in Microbiology·Wei WeiFang Peng
Dec 7, 2016·Oncology Reports·Caterina MusolinoSebastiano Gangemi
Jan 18, 2017·Combinatorial Chemistry & High Throughput Screening·Zhaokun YanJiumao Lin
Dec 25, 2017·Advances in Experimental Medicine and Biology·Waseem Anani, Michael R Shurin
Mar 17, 2018·Current Opinion in Immunology·Evgenii TcyganovDmitry I Gabrilovich
Mar 20, 2018·Frontiers in Immunology·Viktor FlemingViktor Umansky
May 23, 2018·Journal of Immunology Research·Yingjun XieXuewen Zhang
Jul 11, 2018·The American Journal of Chinese Medicine·Sumei WangWanyin Wu
Aug 20, 2018·International Immunopharmacology·Richard P TobinMartin D McCarter
Nov 15, 2018·Frontiers in Immunology·Kim Ohl, Klaus Tenbrock
Dec 6, 2018·International Journal of Cancer. Journal International Du Cancer·Viswanath GundaSareh Parangi
Dec 12, 2018·Journal of Cellular Physiology·Elahe SafariMorteza Motallebnezhad
Feb 26, 2019·Journal of Cellular Physiology·Redouane RouasHussein Fayyad-Kazan
May 28, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Antero SalminenKai Kaarniranta
May 31, 2019·Archives of Pharmacal Research·Su-Myeong Park, Je-In Youn
Jun 14, 2019·Cancer Management and Research·WeiHong RenQinXian Zhang
Jul 3, 2019·Cancer Research·Licia RivoltiniVeronica Huber
Sep 12, 2019·Frontiers in Pharmacology·Jian GaoZhiwei Cao

❮ Previous
Next ❯

Citations

Mar 23, 2021·Frontiers in Cell and Developmental Biology·Jinlong LiuPeng Qu
Aug 11, 2021·Journal of Experimental & Clinical Cancer Research : CR·Yuanyuan ZhengChuanyong Guo

❮ Previous
Next ❯

Methods Mentioned

BETA
Flow cytometry
fluorescence-activated cell sorting
oncotherapy

Software Mentioned

CytExpert

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Asha Jayakumar, Alfred L M Bothwell
International Reviews of Immunology
Baohong YangXiubao Ren
© 2021 Meta ULC. All rights reserved